Achilles Therapeutics (ACHL) Institutional Ownership $1.48 0.00 (0.00%) As of 03/26/2025 Add Compare Share Share Ownership Stock AnalysisChartEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Achilles Therapeutics (NASDAQ:ACHL)CurrentInstitutional OwnershipPercentage56.38%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$3.74MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$828.15K Get ACHL Insider Trade Alerts Want to know when executives and insiders are buying or selling Achilles Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACHL Institutional Buying and Selling by Quarter Achilles Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/8/2025XTX Topco Ltd38,923$58K0.0%+45.1%0.095% 5/7/2025BML Capital Management LLC3,804,921$5.63M4.3%-7.2%9.258% 2/17/2025Two Sigma Advisers LP34,200$39K0.0%+52.7%0.083% 2/17/2025Two Sigma Investments LP61,637$70K0.0%+190.1%0.150% 2/17/2025BNP Paribas Financial Markets50,189$57K0.0%N/A0.122% 2/13/2025XTX Topco Ltd26,824$31K0.0%N/A0.065% 2/13/2025Renaissance Technologies LLC547,233$624K0.0%-14.2%1.331% 11/5/2024BML Capital Management LLC4,100,002$4.18M2.5%+555.8%9.978% 8/12/2024XTX Topco Ltd51,660$42K0.0%+239.4%0.126% 8/9/2024Renaissance Technologies LLC682,734$556K0.0%-32.1%1.662% Get the Latest News and Ratings for ACHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/6/2024Acadian Asset Management LLC250,825$203K0.0%-10.7%0.610% 5/20/2024Virtu Financial LLC20,947$26K0.0%-47.1%0.051% 5/17/2024Artal Group S.A.755,375$944K0.0%-66.5%1.894% 5/17/2024Ikarian Capital LLC1,443,181$1.80M0.2%N/A3.619% 5/15/2024Baker BROS. Advisors LP1,208,775$1.51M0.0%-42.5%3.031% 5/14/2024StemPoint Capital LP1,385,750$1.73M0.5%N/A3.475% 5/10/2024Acadian Asset Management LLC280,929$350K0.0%N/A0.704% 3/7/2024Fcpm Iii Services B.V.2,390,050$2.13M0.6%N/A5.861% 2/14/2024Vestal Point Capital LP108,083$96K0.0%N/A0.265% 5/12/2023Forefront Analytics LLC75,625$72K0.0%+147.7%0.185% 2/14/2023RA Capital Management L.P.1,607,834$1.45M0.0%-67.9%4.107% 11/14/2022Point72 Asset Management L.P.2,107,595$4.76M0.0%+18.6%5.383% 11/14/2022Forefront Analytics LLC32,200$72K0.0%N/A0.082% 8/15/2022Point72 Asset Management L.P.1,776,744$4.48M0.0%+18.4%4.538% 8/15/2022Kettle Hill Capital Management LLC242,978$612K0.2%N/A0.621% 2/15/2022Sender Co & Partners Inc.27,690$139K0.1%N/A0.068% 2/14/2022Point72 Asset Management L.P.1,000,000$5.01M0.0%+100.0%2.463% 2/11/2022Syncona Portfolio Ltd11,086,909$55.55M53.1%N/A27.306% 11/15/2021Point72 Asset Management L.P.500,000$3.90M0.0%N/A1.231% 11/15/2021Sphera Funds Management LTD.242,500$1.89M0.2%-17.0%0.597% 11/15/2021AXA S.A.279,454$2.18M0.0%+3.8%0.688% 11/15/2021Farallon Capital Management LLC450,000$3.51M0.0%-54.8%1.108% 11/12/2021Affinity Asset Advisors LLC100,000$779K0.2%+25.0%0.246% 8/17/2021Woodline Partners LP77,386$758K0.0%-67.6%0.191% 8/17/2021Sphera Funds Management LTD.292,194$2.86M0.2%-2.6%0.719% 8/17/2021Millennium Management LLC196,144$1.92M0.0%-3.3%0.483% 8/16/2021RA Capital Management L.P.5,014,687$49.09M0.8%+261.1%12.345% 8/16/2021Pinz Capital Management LP16,423$161K0.0%+164.8%0.040% 8/16/2021Macquarie Group Ltd.40,402$396K0.0%-26.9%0.099% 8/13/2021Affinity Asset Advisors LLC80,000$783K0.3%+220.0%0.197% This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin8/13/2021AXA S.A.269,135$2.64M0.0%N/A0.663% 8/12/2021JPMorgan Chase & Co.49,405$484K0.0%-92.1%0.122% 8/12/2021Monashee Investment Management LLC64,697$633K0.1%-48.2%0.159% 8/6/2021Sei Investments Co.16,220$159K0.0%N/A0.040% 8/3/2021Peregrine Capital Management LLC225,669$2.21M0.0%-30.0%0.556% 6/10/2021Perceptive Advisors LLC755,375$12.50M0.2%N/A1.860% 5/19/2021Squarepoint Ops LLC28,000$463K0.0%N/A0.069% 5/18/2021Baker BROS. Advisors LP2,591,366$42.89M0.2%N/A6.379% 5/18/2021Millennium Management LLC202,785$3.36M0.0%N/A0.499% 5/18/2021RA Capital Management L.P.1,388,888$22.99M0.3%N/A3.419% 5/18/2021Orbimed Advisors LLC1,584,845$26.23M0.2%N/A3.901% 5/18/2021Redmile Group LLC2,088,089$34.56M0.5%N/A5.140% 5/18/2021Alyeska Investment Group L.P.32,230$533K0.0%N/A0.079% 5/18/2021Boxer Capital LLC1,536,208$25.42M0.9%N/A3.782% 5/18/2021Citadel Advisors LLC39,253$650K0.0%N/A0.097% 5/17/2021Deerfield Management Company L.P. Series C800,000$13.24M0.3%N/A1.969% 5/17/2021Perceptive Advisors LLC755,375$12.50M0.2%N/A1.860% 5/17/2021Woodline Partners LP238,822$3.95M0.1%N/A0.588% 5/17/2021Caas Capital Management LP50,000$828K0.0%N/A0.123% 5/17/2021Pinz Capital Management LP6,203$103K0.0%N/A0.015% 5/17/2021Sphera Funds Management LTD.300,000$4.97M0.4%N/A0.739% 5/7/2021BlackRock Inc.25,000$413K0.0%N/A0.062% (Data available from 1/1/2016 forward) ACHL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACHL shares? During the previous two years, 14 institutional investors and hedge funds held shares of Achilles Therapeutics. The most heavily invested institutionals were BML Capital Management LLC ($5.63M), Fcpm Iii Services B.V. ($2.13M), Ikarian Capital LLC ($1.80M), StemPoint Capital LP ($1.73M), Baker BROS. Advisors LP ($1.51M), Artal Group S.A. ($944K), and Renaissance Technologies LLC ($624K).Learn more on Achilles Therapeutics' institutional investors. What percentage of Achilles Therapeutics' stock is owned by institutional investors? 56.38% of Achilles Therapeutics' stock is owned by institutional investors. Learn more on ACHL's institutional investor holdings. Which institutional investors have been buying Achilles Therapeutics' stock? Of the 10 institutional investors that purchased Achilles Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($3.47M), Fcpm Iii Services B.V. ($2.39M), Ikarian Capital LLC ($1.44M), StemPoint Capital LP ($1.39M), Acadian Asset Management LLC ($280.93K), Vestal Point Capital LP ($108.08K), and XTX Topco Ltd ($75.36K). How much institutional buying is happening at Achilles Therapeutics? Institutional investors have bought a total of 3,652,569 shares in the last 24 months. This purchase volume represents approximately $3.74M in transactions. Which of Achilles Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Achilles Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($413.93K), BML Capital Management LLC ($295.08K), and Acadian Asset Management LLC ($30.10K). How much institutional selling is happening at Achilles Therapeutics? Institutional investors have sold a total of 739,110 shares in the last 24 months. This volume of shares sold represents approximately $828.15K in transactions. Related Companies AARD Major Shareholders TNXP Major Shareholders CADL Major Shareholders IMMP Major Shareholders ACB Major Shareholders SLRN Major Shareholders CGC Major Shareholders TVGN Major Shareholders BTMD Major Shareholders INBX Major Shareholders This page (NASDAQ:ACHL) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Achilles Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
